Roper Industries, Inc. — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2013. The filing identifies the registrant as Roper Industries, Inc. (the request identifies the company as Roper Technologies Inc.). Unless stated otherwise, amounts below are in U.S. dollars.
Financial performance
| Metric | Q3 2013 | Q3 2012 | Nine months 2013 | Nine months 2012 |
|---|---|---|---|---|
| Net sales | $827.8 million | $747.6 million | $2,349.0 million | $2,183.6 million |
| Operating income | $219.3 million | $183.3 million | $584.3 million | $532.3 million |
| Net earnings | $136.3 million | $116.7 million | $372.6 million | $339.8 million |
| Diluted EPS | $1.36 | $1.17 | $3.72 | $3.41 |
- Q3 sales rose 10.7%, with management attributing growth to 3% organic growth and 8% from acquisitions. Gross margin increased to 58.3% from 55.7%; net margin was 16.5% versus 15.6%.
- For the nine months, sales increased 7.6%; gross margin was 57.5% versus 55.2%, and net margin was 15.9% versus 15.6%. Growth was primarily acquisition-driven, with a small negative foreign-exchange impact.
- Operating cash flow was $566.8 million for the nine months, up from $466.2 million. Capital expenditures were $33.3 million; operating cash flow less capital expenditures was approximately $533.4 million.
- Cash and equivalents were $460.0 million at September 30, 2013, versus $370.6 million at year-end 2012. Total debt was $2.606 billion, up from $2.022 billion; net debt was $2.146 billion. Net debt to total net capital increased to 34.6% from 30.9%.
- Working capital, excluding cash and current debt, was $307.3 million, approximately unchanged from $307.8 million at year-end. The company reported $357 million of cash at foreign subsidiaries; repatriating it for domestic use could incur additional taxes.
Material changes and segment trends
- Medical & Scientific Imaging led growth: Q3 sales rose 37.6% and nine-month sales rose 32.8%, driven mainly by acquisitions. MHA, acquired May 1 for approximately $1.0 billion in cash, contributed to this segment. Organic growth was 3% in Q3 but negative 2% for the nine-month period.
- RF Technology sales increased 7.7% in Q3 and 4.5% for nine months, supported by toll and traffic, university card systems, and security solutions.
- Industrial Technology sales were nearly flat in Q3 and down 2.9% for nine months. Energy Systems & Controls sales declined 2.0% in Q3 and 1.2% for nine months.
- Interest expense increased to $24.7 million in Q3 from $16.5 million and to $67.9 million for nine months from $47.0 million, reflecting higher average debt balances related to acquisitions, partly offset by lower average rates.
Outlook, risks, and unusual items
- No specific numerical earnings or revenue guidance was provided. Management expected positive operating cash flow and anticipated it would support debt reduction, while noting that acquisition needs and operating performance could affect the pace.
- The company issued $800 million of 2.05% senior unsecured notes due 2018; proceeds were used partly to repay revolver borrowings. It repaid $500 million of notes that matured in August, using revolver borrowings. Revolver borrowings were $390 million at quarter-end, and the company reported compliance with debt covenants.
- A $9.1 million warranty expense was recorded in the second quarter for replacement of faulty vendor-supplied refrigeration-system valve components. Warranty accruals were $16.0 million at September 30.
- MHA acquisition accounting included a $35 million estimate of pre-acquisition administrative fees receivable and an $8.6 million related customer revenue-share liability; both fair-value adjustments were fully amortized by September 30. The purchase-price allocation remained preliminary for tax-related adjustments.
- Management cited economic and geopolitical uncertainty, acquisition integration and financing, indebtedness and interest rates, foreign exchange, cyclicality, customer concentration, product liability and warranty exposure, litigation, and potential impairment of substantial goodwill and intangible assets as risks. Asbestos-related claims were disclosed; potential liability could not be determined. Management did not expect pending matters, individually or collectively, to materially harm consolidated results, cash flows, or financial position.
- Management reported disclosure controls as effective and no material change in internal control over financial reporting during the quarter.
Key facts investors should verify
- How much reported growth and margin improvement is sustainable organically versus attributable to MHA and other acquisitions.
- Whether operating cash generation can reduce debt while supporting acquisitions, and the resulting interest expense and leverage.
- The operating contribution and integration progress of MHA, including the effects of acquisition accounting on reported revenue and expenses.
- Whether the refrigeration-valve issue creates further warranty costs, and the status of other product-liability and asbestos claims.
- Whether weaker nine-month organic performance in Medical & Scientific Imaging and declines in Industrial Technology and Energy Systems & Controls persist.
- The filing states MHA pro forma results were not provided because the acquisition was not material to operations; no separate MHA revenue or earnings figure is disclosed.